UBS Group AG - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$117,771
-46.6%
11,434
-14.6%
0.00%
Q2 2023$220,634
+125.7%
13,388
+25.5%
0.00%
Q1 2023$97,746
+366.6%
10,671
+264.7%
0.00%
Q4 2022$20,950
-65.1%
2,926
-75.5%
0.00%
Q3 2022$60,000
+757.1%
11,955
+300.6%
0.00%
Q2 2022$7,000
-69.6%
2,984
-9.8%
0.00%
Q1 2022$23,000
-65.7%
3,307
-60.0%
0.00%
Q4 2021$67,000
-81.4%
8,258
-77.6%
0.00%
Q3 2021$361,000
+296.7%
36,901
+173.7%
0.00%
Q2 2021$91,000
+44.4%
13,484
+96.3%
0.00%
Q1 2021$63,000
+96.9%
6,868
+45.9%
0.00%
Q4 2020$32,000
+60.0%
4,708
+18.4%
0.00%
Q3 2020$20,000
-47.4%
3,975
-15.3%
0.00%
Q2 2020$38,000
+46.2%
4,694
+45.6%
0.00%
Q1 2020$26,000
-51.9%
3,225
-55.3%
0.00%
Q4 2019$54,000
+200.0%
7,220
+62.2%
0.00%
Q3 2019$18,000
+200.0%
4,450
+121.8%
0.00%
Q2 2019$6,0002,006
+1828.8%
0.00%
Q1 2019$0
-100.0%
104
-96.7%
0.00%
Q4 2018$8,000
-69.2%
3,179
-47.2%
0.00%
Q3 2018$26,000
-10.3%
6,017
+28.1%
0.00%
Q2 2018$29,000
+262.5%
4,696
+288.4%
0.00%
Q1 2018$8,000
-50.0%
1,209
-38.0%
0.00%
Q4 2017$16,000
+1500.0%
1,949
+3509.3%
0.00%
Q3 2017$1,000
-96.4%
54
-97.8%
0.00%
Q2 2017$28,000
+1300.0%
2,492
+1816.9%
0.00%
Q1 2017$2,0001300.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders